GEHC

GE HealthCare Technologies
D

GEHC

Arincen60/100B
82.385
USD
-1.36
(-1.62%)
Post Trading·82.380USD-0.005(-0.01%)
Fair value76.47Plus+8%51Price 82.39119
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
OverviewFinancialsForecastEarningsDividendsCompany

GE HealthCare Technologies net income 2019–2026

GE HealthCare Technologies earned 614.00M USD in Q3 FY2026, the three months to 30 September 2026, up 37.7% on the same quarter a year before. GE HealthCare Technologies's net income over the last twelve months was 1.76B USD, down 20.6% on the twelve months before. In fiscal year 2025 it earned 2.08B USD, up 4.6% on the year before.

Last updated 7 Nov 2026 · Next report 3 Feb 2027

Net income

Net income · +5.4% a year over 6 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 20261.76B-20.58%8.54%20.61B
FY202531 Dec 20252.08B+4.57%10.10%20.63B
FY202431 Dec 20241.99B+27.10%10.13%19.67B
FY202331 Dec 20231.57B-18.16%8.02%19.55B
FY202231 Dec 20221.92B-14.73%10.45%18.34B
FY202131 Dec 20212.25B-83.77%12.78%17.59B
FY202031 Dec 202013.85B+808.53%80.67%17.16B
FY201931 Dec 20191.52B—9.16%16.63B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Income statement

Common questions about GE HealthCare Technologies's profit

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.